Epigenetic Mediation of <i>AKT1</i> rs1130233’s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing

Epigenetic Mediation of <i>AKT1</i> rs1130233’s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing

High doses of delta-9-tetrahydrocannabinol (THC), the main psychoactive component of cannabis, have been shown to have anxiogenic effects. Additionally, THC effects have been shown to be modulated by genotype, including the single nucleotide polymorphism (SNP) rs1130233 at the protein kinase <i&g...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Grace Blest-Hopley, Marco Colizzi, Diana Prata, Vincent Giampietro, Michael Brammer, Philip McGuire, Sagnik Bhattacharyya
Natura:	Articolo
Lingua:	English
Pubblicazione:	MDPI AG 2021-09-01
Serie:	Brain Sciences
Soggetti:	THC cannabis Marijuana <i>AKT1</i> Epigenetics fMRI
Accesso online:	https://www.mdpi.com/2076-3425/11/9/1240

Documenti analoghi

Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
di: Grace Blest-Hopley, et al.
Pubblicazione: (2020-08-01)

A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations
di: Grace Blest-Hopley, et al.
Pubblicazione: (2020-02-01)

<i>Cannabis sativa</i> L.: Crop Management and Abiotic Factors That Affect Phytocannabinoid Production
di: Ingrid Trancoso, et al.
Pubblicazione: (2022-06-01)

Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
di: Jamie Corroon, et al.
Pubblicazione: (2019-12-01)

Differentiating Cannabis Products: Drugs, Food, and Supplements
di: Arash Salehi, et al.
Pubblicazione: (2022-06-01)

Prenatal delta-9-tetrahydrocannabinol exposure is associated with changes in rhesus macaque DNA methylation enriched for autism genes
di: Lyndsey E. Shorey-Kendrick, et al.
Pubblicazione: (2023-07-01)

Sociodemographic characteristics and correlates of Delta-8 THC use in US adults
di: O. Livne
Pubblicazione: (2022-06-01)

Do Cannabis Users Reduce Their THC Dosages When Using More Potent Cannabis Products? A Review
di: Janni Leung, et al.
Pubblicazione: (2021-02-01)

The Impact of THC and CBD in Schizophrenia: A Systematic Review
di: Saeed Ahmed, et al.
Pubblicazione: (2021-07-01)

Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
di: Jerome Sarris, et al.
Pubblicazione: (2020-01-01)

Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
di: Mina G. Nashed, et al.
Pubblicazione: (2021-01-01)

Legalization of marijuana or not? Opinions from over 38,000 residents in Taiwan
di: Kuo-Yu Chao, et al.
Pubblicazione: (2023-10-01)

Online survey of medicinal cannabis users: Qualitative analysis of patient-level data
di: Albert Garcia-Romeu, et al.
Pubblicazione: (2022-09-01)

Case report: Treatment of non-medical tetrahydrocannabinol toxicosis with transmucosal cannabidiol-infused dissolving sheets in six dogs
di: Kyra Marsigliano, et al.
Pubblicazione: (2024-12-01)

Cannabinoids, Endocannabinoids and Sleep
di: Andrew J. Kesner, et al.
Pubblicazione: (2020-07-01)

Observational Analysis of the Influence of Medical Marijuana Use on Quality of Life in Patients
di: Mark D. Kelley, et al.
Pubblicazione: (2024-02-01)

Detection of Δ9-tetrahydrocannabinol (THC) in hair using GC–MS
di: Himanshu Khajuria, et al.
Pubblicazione: (2014-03-01)

The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
di: Fatma Haddad, et al.
Pubblicazione: (2022-05-01)

Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function
di: Staci A Gruber, et al.
Pubblicazione: (2016-10-01)

Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial
di: Sukpiriyagul A, et al.
Pubblicazione: (2023-08-01)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
di: Lourdes Poyatos, et al.
Pubblicazione: (2020-06-01)

Marijuana use in U.S. teen drivers: a comparison of a road-side survey of reported use and fluid tests for tetrahydrocannabinol (THC)
di: Joyce C. Pressley, et al.
Pubblicazione: (2019-05-01)

Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction
di: Xinwen Chang, et al.
Pubblicazione: (2017-06-01)

Acute effects of Delta-9-Tetrahydrocannabinol on performance monitoring in healthy volunteers
di: Desiree eSpronk, et al.
Pubblicazione: (2011-09-01)

The Combination of High-Fat Diet and Oral Marijuana Promotes the Development of Fibrosis in the Mouse Corpora Cavernosa
di: Sabine Nguyen, DO, et al.
Pubblicazione: (2021-04-01)

Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans
di: Marco Colizzi, et al.
Pubblicazione: (2019-04-01)

A Systematic Review of Delta-9-Tetrahydrocannabinol (∆9-THC) in Astrocytic Markers
di: Christian Ramos-Jiménez, et al.
Pubblicazione: (2024-09-01)

<i>Cannabis</i>-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability
di: Francesca Baratta, et al.
Pubblicazione: (2021-02-01)

Pharmacokinetics of delta-9-tetrahydrocannabinol following acute cannabis smoke exposure in mice; effects of sex, age, and strain
di: Emely A. Gazarov, et al.
Pubblicazione: (2023-08-01)

<i>Cannabis</i>-Based Oral Emulsion for Medical Purposes to Meet the Needs of Patients: Formulation, Quality and Stability
di: Francesca Baratta, et al.
Pubblicazione: (2022-02-01)

Proteomic Profile of Circulating Extracellular Vesicles in the Brain after Δ9-Tetrahydrocannabinol Inhalation
di: Valeria Lallai, et al.
Pubblicazione: (2024-09-01)

Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies
di: Ana Maria Raymundi, et al.
Pubblicazione: (2020-08-01)

Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis
di: Rahul Nachnani, et al.
Pubblicazione: (2024-05-01)

Use of non-medical cannabis in epilepsy: A scoping review
di: Jimmy Li, et al.
Pubblicazione: (2023-03-01)

Release of delta-9-tetrahydrocannabinol from polyvinyl alcohol hydrogels and its safe interaction with human skin fibroblasts
di: Shujun Cui, et al.
Pubblicazione: (2024-01-01)

Association between <i>ABCB1</i> rs2235048 Polymorphism and THC Pharmacokinetics and Subjective Effects following Smoked Cannabis in Young Adults
di: Justin Matheson, et al.
Pubblicazione: (2022-09-01)

A Model of Combined Exposure to Nicotine and Tetrahydrocannabinol via Electronic Cigarettes in Pregnant Rats
di: Kristen R. Breit, et al.
Pubblicazione: (2022-03-01)

The Effect of Harvest Date on Temporal Cannabinoid and Biomass Production in the Floral Hemp (<i>Cannabis sativa</i> L.) Cultivars BaOx and Cherry Wine
di: Eric R. Linder, et al.
Pubblicazione: (2022-10-01)

The Past, Present and Future of <i>Cannabis sativa</i> Tissue Culture
di: Adrian S. Monthony, et al.
Pubblicazione: (2021-01-01)

Intraperitoneal delivery of cannabidiol (CBD) and Δ9-tetrahydocannabinol (THC) promotes papillomavirus infections in athymic nude mice
di: Sarah A. Brendle, et al.
Pubblicazione: (2025-06-01)